Multiple Sclerosis Treatment

ZINCARE

M. Chomba

Use of Advanced Imaging and AI in Diagnosis and Treatment of Multipl…

Houston Methodist

A. R. Alchaki

ECTRIMS 2024 Insights: Real-World Evidence on Infection-Related Hosp…

Afagh Garjani

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

Vascular Dementia and NPH

ZINCARE

A. Hillis

Paramagnetic Rim Lesions Predict Greater Long-Term Relapse Rates and…

Jack A. Reeves

Multiple Sclerosis for the Non-Neurologist

Providence Swedish

J. D. Bowen

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

Unpacking Parkinsonism: Understanding Movement Changes in LBD

Lewy Body Dementia Association

J. Fleisher

Dry Needling & High Tech Mobility Devices for the Lower Extremity

Cleveland Clinic Neurological Institute

A. Gaglione

Therapeutic Approaches for Multiple Sclerosis: What We Know and What…

Cleveland Clinic Nevada

C. Hersh

Inflammatory Management in Multiple Sclerosis: The Complementary Med…

Women Neurologists Group (WNG)

M. Rensel

The Connection Between Viruses and Other Factors Contributing to the…

The France Foundation

M. Levy

Autonomic Symptoms in Lewy Body Dementia

Lewy Body Dementia Association

S. Chiu

Neural effects of fatigue on cognition in relapsing MS detected by m…

2023 Conference Coverage

A. Memon